Advertisement

Topics

Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics

16:57 EST 14 Dec 2017 | News-Medical.net

Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug.

Original Article: Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics

NEXT ARTICLE

More From BioPortfolio on "Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...